Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
Tuberculosis
•
Pulmonology
•
Pulmonary Infections
•
Primary Care
Do you routinely monitor imaging or pulmonary function in patients with pulmonary TB after the completion of therapy?
Answer from: at Community Practice
The simple answer will be: NO.
Sign in or Register to read more
17975
Related Questions
How would you approach treatment of latent TB for patients who cannot tolerate rifamycins or isoniazid due to allergy, intolerance, or drug-drug interactions?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
How do you manage resistant infections that persist after stopping antibiotic therapy in patients with non-CF bronchiectasis?
Are there clinical scenarios in which you would start empiric treatment for pulmonary TB without microbiologic confirmation?
What is your approach to prescribing RIPE for 6 month vs rifapentine/moxifloxacin for 4 months in the treatment of drug sensitive TB in the US?
What is your approach to duration of antibiotic therapy for treatment of a bacterial lung abscess?
What is the interpretation of an IGRA with positive TB wells and negative nil and negative mitogen wells?
What is the interpretation of two IGRAs with negative mitogen wells, in the absence of immunosuppression?
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?
Do you consider the use of tocilizumab in patients with COVID pneumonia who have had an improvement in supplemental O2 requirements but have significantly elevated inflammatory markers after day two of remdesivir and dexamethasone?